These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 632564)

  • 1. Immunity to challenge in volunteers vaccinated with an inactivated current or earlier strain of influenza A(H3N2).
    Larson HE; Tyrrell DA; Bowker CH; Potter CW; Schild GC
    J Hyg (Lond); 1978 Apr; 80(2):243-8. PubMed ID: 632564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunity to attenuated influenza virus WRL 105 infection induced by heterologous, inactivated influenza A virus vaccines.
    Potter CW; Jennings R; Nicholson K; Tyrrell DA; Dickinson KG
    J Hyg (Lond); 1977 Dec; 79(3):321-32. PubMed ID: 270523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A graded-dose study of inactivated, surface antigen influenza B vaccine in volunteers: reactogenicity, antibody response and protection to challenge virus infection.
    Goodeve A; Potter CW; Clark A; Jennings R; Schild GC; Yetts R
    J Hyg (Lond); 1983 Feb; 90(1):107-15. PubMed ID: 6822725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural challenge of subjects vaccinated with WRL 105 strain live influenza vaccine in a residential community.
    Morris CA; Freestone DS; Stealey VM
    Dev Biol Stand; 1976; 33():197-201. PubMed ID: 782969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical imiquimod before intradermal trivalent influenza vaccine for protection against heterologous non-vaccine and antigenically drifted viruses: a single-centre, double-blind, randomised, controlled phase 2b/3 trial.
    Hung IF; Zhang AJ; To KK; Chan JF; Li P; Wong TL; Zhang R; Chan TC; Chan BC; Wai HH; Chan LW; Fong HP; Hui RK; Kong KL; Leung AC; Ngan AH; Tsang LW; Yeung AP; Yiu GC; Yung W; Lau JY; Chen H; Chan KH; Yuen KY
    Lancet Infect Dis; 2016 Feb; 16(2):209-18. PubMed ID: 26559482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody responses and resistance to challenge in volunteers vaccinated with live attenuated, detergent split and oil adjuvant A2-Hong Kong-68 (H 3 N 2 ) influenza vaccines. A report to the Medical Research Council Committee on Influenza and other Respiratory Virus Vaccines.
    Freestone DS; Hamilton-Smith S; Schild GC; Buckland R; Chinn S; Tyrrell DA
    J Hyg (Lond); 1972 Sep; 70(3):531-43. PubMed ID: 4506997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of live and inactivated influenza A (H1N1) virus vaccines. 2. Long-term immunity.
    Clark A; Potter CW; Jennings R; Nicholl JP; Langrick AF; Schild GC; Wood JM; Tyrrell DA
    J Hyg (Lond); 1983 Jun; 90(3):361-70. PubMed ID: 6863910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of antibody responses and reactivity of "Alice" and WRL 105 strain live influenza vaccines.
    Morris CA; Stealey VM; Freestone DS; Porter DA
    Lancet; 1976 May; 1(7969):1118-20. PubMed ID: 57520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody responses to vaccination with WRL 105 strain live influenza vaccine in previously vaccinated and unvaccinated volunteers.
    Evans AE; Simmons RL; Ferris RD; Hasell SK; Letley E; Freestone DS
    J Hyg (Lond); 1979 Jun; 82(3):489-95. PubMed ID: 448065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination-challenge studies with a Port Chalmers/73 (H3N2)-based swine influenza virus vaccine: Reflections on vaccine strain updates and on the vaccine potency test.
    De Vleeschauwer A; Qiu Y; Van Reeth K
    Vaccine; 2015 May; 33(20):2360-6. PubMed ID: 25804707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characterization of live recombinant influenza vaccine.
    Stealey VM; McCahon D; Freestone DS
    Dev Biol Stand; 1976; 33():191-6. PubMed ID: 955267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary results of oral influenza vaccination with live attenuated viruses.
    DeBarbieri A; Crovari P; Cuneo-Crovari P; Badolati G; Giacometti G
    Dev Biol Stand; 1976; 33():213-9. PubMed ID: 782972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A contribution of cellular immunity to protection against influenza in man.
    Jennings R; Fenton RJ; McEntegart MG; Potter CW
    Med Microbiol Immunol; 1978 Nov; 166(1-4):51-62. PubMed ID: 723791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza at Christ's Hospital: March, 1974.
    Hoskins TW; Davies JR; Smith AJ; Allchin A; Miller CL; Pollock TM
    Lancet; 1976 Jan; 1(7951):105-8. PubMed ID: 54631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative trials of live attenuated and detergent split influenza virus vaccines.
    Mackenzie JS; Mackenzie I; Lloyd J; Dent V
    J Hyg (Lond); 1975 Dec; 75(3):425-43. PubMed ID: 1059709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of acute respiratory disease in the community of Port Chalmers. III. Efficacy of influenza virus subunit vaccines in 1973, 1974 and 1975.
    Jennings LC; MacDiarmid RD; Miles JA
    N Z Med J; 1980 Sep; 92(668):230-3. PubMed ID: 6935541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses.
    Hobson D; Curry RL; Beare AS; Ward-Gardner A
    J Hyg (Lond); 1972 Dec; 70(4):767-77. PubMed ID: 4509641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of ferrets to infection with a live attenuated influenza virus and to subsequent heterologous challenge.
    Delem A
    Dev Biol Stand; 1976; 33():226-33. PubMed ID: 955269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A one-year study of trivalent influenza vaccines in primed and unprimed volunteers: immunogenicity, clinical reactions and protection.
    Masurel N; Laufer J
    J Hyg (Lond); 1984 Jun; 92(3):263-76. PubMed ID: 6736638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial Protection Induced by 2011-2012 Influenza Vaccine Against Serologically Evidenced A(H3N2) Influenza Virus Infections in Elderly Institutionalized People.
    Camilloni B; Basileo M; Menculini G; Tozzi P; Iorio AM
    Adv Exp Med Biol; 2016; 897():45-53. PubMed ID: 26577530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.